N-(1-Hydroxy-2-oxo-2-phenylethyl)benzamide - CAS 2166-87-2
Catalog: |
BB058836 |
Product Name: |
N-(1-Hydroxy-2-oxo-2-phenylethyl)benzamide |
CAS: |
2166-87-2 |
Synonyms: |
N-(1-hydroxy-2-oxo-2-phenylethyl)benzamide |
IUPAC Name: | N-(1-hydroxy-2-oxo-2-phenylethyl)benzamide |
Description: | N-(1-hydroxy-2-oxo-2-phenylethyl)benzamide (cas# 2166-87-2) is a useful research chemical. |
Molecular Weight: | 255.27 |
Molecular Formula: | C15H13NO3 |
Canonical SMILES: | C1=CC=C(C=C1)C(=O)C(NC(=O)C2=CC=CC=C2)O |
InChI: | InChI=1S/C15H13NO3/c17-13(11-7-3-1-4-8-11)15(19)16-14(18)12-9-5-2-6-10-12/h1-10,15,19H,(H,16,18) |
InChI Key: | JWVPVXMVKOSSRU-UHFFFAOYSA-N |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P273, P301+P316, P321, P330, P391, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CA-1270814-A | 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives | 19850418 |
CS-255871-B2 | Process for preparing derivatives of 6-/1-acyl-1-hydrohymethyl/-penicillanic acid | 19850418 |
EP-0201221-A1 | 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives | 19850418 |
EP-0201221-B1 | 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives | 19850418 |
FI-85272-B | ANALOGIFICATE FARING FOR THERAPEUTIC USE OF THERAPEUTIC MEASURE 6- (1-ACYL-1-HYDROXIMETYL) PENICILLANSYRADERIVAT. | 19850418 |
FI-85272-C | Analogous Process for Preparing Therapeutically Useful 6- (1-Acyl-1-Hydroxymethyl) Penicillanic Acid Derivatives | 19850418 |
HU-196807-B | Process for producing 6-/1-acyl-1-hydroxy-methyl/-penicillanic acid derivatives | 19850418 |
IE-58666-B1 | 6-(1-Acyl-1-hydroxymethyl) pencillanic acid derivatives | 19850418 |
KR-880000974-B1 | 6- (1-acyl-1-hydroxymethyl) phenicylic acid derivative and preparation method thereof | 19850418 |
PL-147619-B1 | Method of obtaining novel derivatives of 6-/1-acyl-1-hydromethyl/penicillanic acid | 19850418 |
PMID | Publication Date | Title | Journal |
1959 | 19751101 | [Comparative study of a new antihistamine, mequitazine, and placebos] | Acta allergologica |
Complexity: | 317 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 255.08954328 |
Formal Charge: | 0 |
Heavy Atom Count: | 19 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 255.08954328 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 66.4Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS